Published in Blood on March 15, 2000
Tissue factor pathway inhibitor: structure-function. Front Biosci (Landmark Ed) (2012) 1.28
Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants. Blood (2005) 0.91
Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature (1999) 8.70
Intracellular site of asialoglycoprotein receptor-ligand uncoupling: double-label immunoelectron microscopy during receptor-mediated endocytosis. Cell (1983) 6.89
Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect of lysosomotropic agents. J Biol Chem (1983) 4.55
Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays (2000) 4.38
Intracellular receptor sorting during endocytosis: comparative immunoelectron microscopy of multiple receptors in rat liver. Cell (1984) 3.96
Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int (2006) 3.00
Factor XI activation in a revised model of blood coagulation. Science (1991) 2.87
Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc Natl Acad Sci U S A (1991) 2.77
Membranes of sorting organelles display lateral heterogeneity in receptor distribution. J Cell Biol (1987) 2.59
The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor. EMBO J (1996) 2.58
Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol (2001) 2.52
Late endosomes derive from early endosomes by maturation. Cell (1991) 2.41
The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death. Proc Natl Acad Sci U S A (1998) 2.40
Kinetics of internalization and recycling of the asialoglycoprotein receptor in a hepatoma cell line. J Biol Chem (1982) 2.35
Pulmonary tuberculosis in AIDS patients: transient chest radiographic worsening after initiation of antiretroviral therapy. AJR Am J Roentgenol (2000) 2.20
Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies. J Immunol (1984) 2.18
Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70. J Biol Chem (1997) 2.14
Identification of a new variable sequence in the P1 cytadhesin gene of Mycoplasma pneumoniae: evidence for the generation of antigenic variation by DNA recombination between repetitive sequences. Infect Immun (1999) 2.11
The asialoglycoprotein receptor internalizes and recycles independently of the transferrin and insulin receptors. Cell (1983) 2.10
Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem (1988) 2.09
Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature (1989) 2.07
Alterations in the protein composition of maturing phagosomes. J Clin Invest (1992) 2.07
Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. N Engl J Med (1976) 2.04
Characterization of the asialoglycoprotein receptor in a continuous hepatoma line. J Biol Chem (1981) 2.04
Recycling of the asialoglycoprotein receptor and the effect of lysosomotropic amines in hepatoma cells. J Cell Biol (1984) 2.04
39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein. EMBO J (1995) 1.98
Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood (1997) 1.94
The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X. Anal Biochem (1980) 1.89
Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc Natl Acad Sci U S A (1998) 1.88
Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator. Proc Natl Acad Sci U S A (1992) 1.88
The ubiquitin-mediated proteolytic pathway: mechanisms of recognition of the proteolytic substrate and involvement in the degradation of native cellular proteins. FASEB J (1994) 1.84
Relations between the intracellular pathways of the receptors for transferrin, asialoglycoprotein, and mannose 6-phosphate in human hepatoma cells. J Cell Biol (1989) 1.74
Isolation and structure of the bacterial sex pheromone, cAD1, that induces plasmid transfer in Streptococcus faecalis. FEBS Lett (1984) 1.73
Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood (1988) 1.72
Protein synthesis elongation factor EF-1 alpha is essential for ubiquitin-dependent degradation of certain N alpha-acetylated proteins and may be substituted for by the bacterial elongation factor EF-Tu. Proc Natl Acad Sci U S A (1994) 1.72
Sequence of human asialoglycoprotein receptor cDNA. An internal signal sequence for membrane insertion. J Biol Chem (1985) 1.71
Trabecular surgery. Arch Ophthalmol (1974) 1.71
Modulators of cyclic AMP metabolism induce syncytiotrophoblast formation in vitro. Exp Cell Res (1990) 1.70
Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J Neurochem (1997) 1.67
How are substrates recognized by the ubiquitin-mediated proteolytic system? Trends Biochem Sci (1989) 1.66
Biosynthesis of the human asialoglycoprotein receptor. J Biol Chem (1983) 1.65
Immunoelectron microscopic localization of acidic intracellular compartments in hepatoma cells. EMBO J (1985) 1.64
Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial. Br J Cancer (2003) 1.63
Bleb leak with hypotony after laser suture lysis and trabeculectomy with mitomycin C. Arch Ophthalmol (1992) 1.63
A glomerular permeability factor produced by human T cell hybridomas. Kidney Int (1991) 1.61
Purification and properties of human coagulation factor VII. J Biol Chem (1980) 1.61
The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications. J Cell Biochem Suppl (2000) 1.61
Functional and ultrastructural evidence for intracellular formation of major histocompatibility complex class II-peptide complexes during antigen processing. Proc Natl Acad Sci U S A (1990) 1.60
Binding of human factor VII and VIIa to monocytes. J Clin Invest (1982) 1.60
Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood Flow Metab (1988) 1.59
Identification of a novel ubiquitin conjugation motif, required for ligand-induced internalization of the growth hormone receptor. EMBO J (1999) 1.58
Age-dependent prevalence of mutations at the GLC1A locus in primary open-angle glaucoma. Am J Ophthalmol (2000) 1.57
Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. Science (1990) 1.56
Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci U S A (1995) 1.56
SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase. EMBO J (2000) 1.55
Isolation of a protein Z-dependent plasma protease inhibitor. Proc Natl Acad Sci U S A (1998) 1.55
Synthesis and assembly of membrane and organelle proteins. Int Rev Cytol Suppl (1981) 1.55
Effect of lysosomotropic amines on the secretory pathway and on the recycling of the asialoglycoprotein receptor in human hepatoma cells. J Cell Biol (1985) 1.50
Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood (1996) 1.50
A murine model of factor XI deficiency. Blood Coagul Fibrinolysis (1997) 1.49
Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes. Mol Cell Biol (1995) 1.48
Dissection of receptor folding and ligand-binding property with functional minireceptors of LDL receptor-related protein. J Cell Sci (2001) 1.48
Transport of phagosomal components to an endosomal compartment. J Biol Chem (1992) 1.47
Identification and quantification of the rat hepatocyte asialoglycoprotein receptor. Proc Natl Acad Sci U S A (1981) 1.47
Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor. J Biol Chem (1998) 1.46
Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa. Blood (1992) 1.46
Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. J Biol Chem (1989) 1.45
Linkage of the ubiquitin-conjugating system and the endocytic pathway in ligand-induced internalization of the growth hormone receptor. EMBO J (1997) 1.44
Difficulties in the quantification of asialoglycoprotein receptors on the rat hepatocyte. J Biol Chem (1980) 1.43
Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry (1987) 1.43
Argon laser trabecular surgery in uncontrolled phakic open angle glaucoma. Ophthalmology (1981) 1.42
The protein Z-dependent protease inhibitor is a serpin. Biochemistry (1999) 1.41
Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J Biol Chem (1994) 1.41
Characterization of the protein Z-dependent protease inhibitor. Blood (2000) 1.41
The hepatic asialoglycoprotein receptor. CRC Crit Rev Biochem (1984) 1.41
Immunocytochemical localization of the receptor for asialoglycoprotein in rat liver cells. J Cell Biol (1982) 1.40
Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase. Blood (1996) 1.39
Cell biology of the asialoglycoprotein receptor system: a model of receptor-mediated endocytosis. Int Rev Cytol (1985) 1.39
Molecular cloning, sequence, and tissue distribution of the human ubiquitin-activating enzyme E1. Proc Natl Acad Sci U S A (1991) 1.38
Overproduction of antiplatelet antibody against glycoprotein IIb after splenectomy in a patient with Evans syndrome resulting in acquired thrombasthenia. Acta Haematol (1998) 1.38
Degradation of proteins with acetylated amino termini by the ubiquitin system. Science (1989) 1.37
Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. Blood (1991) 1.37
Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein. Thromb Res (1989) 1.37
Sorting and recycling of cell surface receptors and endocytosed ligands: the asialoglycoprotein and transferrin receptors. J Cell Biochem (1983) 1.37
Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor. Thromb Haemost (2001) 1.36
Encephalitis and retarded growth of chicks caused by Sitiawan virus, a new isolate belonging to the genus Flavivirus. Am J Trop Med Hyg (2001) 1.35
Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice. Circulation (2001) 1.35
A tail vein bleeding time model and delayed bleeding in hemophiliac mice. Thromb Haemost (2001) 1.33
Subcellular localization and endocytic function of low density lipoprotein receptor-related protein in human glioblastoma cells. J Biol Chem (1994) 1.30
Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood (2001) 1.30
A cycloheximide-resistant pool of receptors for asialoglycoproteins and mannose 6-phosphate residues in the Golgi complex of hepatocytes. EMBO J (1984) 1.29
Human Protein Z. J Clin Invest (1984) 1.28
Psychometric testing of fatigue instruments for use with cancer patients. Nurs Res (2000) 1.28
An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein. Proc Natl Acad Sci U S A (1985) 1.26
Kinetics of factor Xa inhibition by tissue factor pathway inhibitor. J Biol Chem (1993) 1.23
The pathway of the asialoglycoprotein-ligand during receptor-mediated endocytosis: a morphological study with colloidal gold/ligand in the human hepatoma cell line, Hep G2. Eur J Cell Biol (1983) 1.23
The effect of leukocyte elastase on tissue factor pathway inhibitor. Blood (1992) 1.22
Structural motifs involved in ubiquitin-mediated processing of the NF-kappaB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domain. Mol Cell Biol (1999) 1.22
Prothrombotic phenotype of protein Z deficiency. Proc Natl Acad Sci U S A (2000) 1.21